seri
thiosemicarbazon
analogu
contain
thiochromanon
molecular
scaffold
function
primarili
posit
prepar
chemic
synthesi
evalu
inhibitor
cathepsin
l
b
promis
inhibitor
group
select
cathepsin
l
demonstr
ic
valu
low
nanomolar
rang
nearli
case
thiochromanon
sulfid
analogu
show
superior
inhibit
cathepsin
l
compar
correspond
thiochromanon
sulfon
deriv
without
except
compound
evalu
inact
ic
nm
cathepsin
b
potent
inhibitor
ic
nm
cathepsin
l
prove
analogu
small
librari
compound
significantli
expand
relationship
known
small
molecul
nonpeptid
inhibitor
cathepsin
l
five
class
proteas
includ
matrix
metalloproteas
mmp
cystein
proteas
serin
proteas
aspart
proteas
threonin
proteas
catalyz
hydrolysi
peptid
bond
function
mani
diseas
state
includ
cancer
metastasi
cardiovascular
diseas
proteas
becom
wellinvestig
therapeut
target
cystein
proteas
cathepsin
member
papain
famili
recent
valid
import
enzymat
class
target
cancer
research
famili
cathepsin
enzym
known
date
human
b
c
f
h
k
l
v
w
x
odanacatib
inhibitor
cathepsin
k
develop
merck
current
phase
iii
clinic
trial
treatment
osteoporosi
cathepsin
found
highest
concentr
cellular
lysosom
cancer
progress
secret
increas
rate
degrad
extracellular
matrix
basement
membran
aid
cancer
metastasi
small
molecul
inhibitor
cathepsin
l
previous
identifi
figur
includ
azapenon
cyanamid
deriv
ii
purin
nitril
analogu
iii
well
amino
acidbas
molecul
includ
oxocarbaz
analogu
iv
epoxid
deriv
v
although
structur
similar
activ
site
individu
cathepsin
small
signific
differ
size
shape
take
advantag
differ
facilit
design
select
inhibitor
previou
research
group
focus
inhibitor
cystein
proteas
cruzain
implic
treatment
chaga
diseas
preliminari
assay
evalu
select
cruzain
inhibit
seri
compound
also
screen
structur
similar
human
cystein
proteas
cathepsin
l
sever
compound
base
primarili
benzophenon
thiochromanon
thiosemicarbazon
molecular
structur
identifi
lead
compound
inhibitor
cathepsin
l
origin
find
provid
foundat
support
current
studi
involv
function
thiochromanon
thiosemicarbazon
inhibitor
cathepsin
l
best
knowledg
first
report
thiochromanon
thiosemicarbazon
correspond
sulfon
analogu
molecular
scaffold
inhibit
cathepsin
l
sampl
previous
report
inhibitor
figur
contain
thiosemicarbazon
moieti
includ
vi
vii
viii
ix
incorpor
structur
divers
within
aryl
portion
target
compound
shown
scheme
acid
react
variou
commerci
avail
thiophenol
appropri
function
aromat
ring
result
carboxyl
acid
intermedi
underw
ringclos
reaction
upon
treatment
polyphosphor
acid
ppa
produc
function
thiochromanon
analogu
condens
result
keton
moieti
thiosemicarbazid
afford
thiosemicarbazon
deriv
good
yield
correspond
analogu
prepar
analog
fashion
oxid
obtain
sulfon
deriv
prior
condens
reaction
addit
synthet
step
necessari
prepar
analogu
tabl
support
inform
bromin
unsubstitut
commerci
avail
thiochromanon
afford
serv
start
materi
synthesi
analogu
prepar
hydroxi
analogu
involv
demethyl
reduct
introduc
amin
function
analogu
subsequ
acyl
provid
amid
analogu
geometr
isom
e
z
possibl
nonsymmetr
thiosemicarbazon
analogu
interest
note
except
two
compound
evid
isomer
mixtur
observ
nmr
hplc
compound
studi
furthermor
nuclear
overhaus
effect
spectroscopi
noesi
studi
carri
compound
suggest
presenc
eisom
compound
addit
singlecryst
xray
diffract
studi
compound
indic
eisom
detail
regard
noesi
xray
studi
locat
support
inform
thiochromanon
thiosemicarbazon
analogu
evalu
abil
inhibit
cathepsin
l
b
separ
assay
gener
sulfid
seri
analogu
activ
term
cathepsin
l
inhibit
correspond
sulfon
deriv
individu
ic
valu
either
much
activ
equival
activ
inhibitor
cathepsin
l
studi
analogu
analogu
ic
valu
nm
respect
lower
ic
valu
compound
suggest
substitut
posit
product
incorpor
bromin
atom
posit
compound
result
improv
inhibit
cathepsin
l
compar
fluorin
chlorin
atom
replac
compound
increas
aliphat
substitu
size
posit
compar
compound
reflect
dramat
decreas
inhibit
cathepsin
l
compound
strong
inhibitor
cathepsin
l
interest
note
incorpor
slightli
electrondon
methyl
group
compound
strongli
electronwithdraw
trifluoromethyl
group
compound
case
led
excel
inhibitor
cathepsin
l
incorpor
hydroxyl
amino
methoxi
thiomethyl
acetamid
function
compound
led
loss
cathepsin
l
inhibit
substitut
sulfon
compound
demonstr
signific
inhibit
cathepsin
l
although
less
activ
sulfid
counterpart
compound
trifluoromethyl
sulfon
compar
activ
correspond
sulfid
compound
evalu
studi
inact
cathepsin
b
ic
nm
reflect
select
ratio
cathepsin
lcathepsin
b
activ
cathepsin
l
inhibitor
inhibit
cathepsin
l
assay
sensit
experiment
paramet
preincub
time
substrat
concentr
therefor
difficult
compar
ic
valu
absolut
sens
obtain
small
molecul
inhibitor
cathepsin
l
separ
laboratori
vari
experiment
condit
perspect
mind
encourag
note
potent
thiochromanon
thiosemicarbazon
inhibitor
cathepsin
l
describ
studi
demonstr
activ
compar
exemplari
benzophenon
thiosemicarbarzon
inhibitor
vii
figur
assay
compar
condit
summari
focus
small
librari
analogu
divers
function
nine
found
potent
inhibitor
cathepsin
l
ic
nm
two
activ
analogu
thiosemicarba
author
declar
follow
compet
financi
interest
correspond
author
kgp
disclos
potenti
conflict
interest
regard
paid
consult
relationship
oxigen
inc
grate
dr
kevin
k
klausmey
valuabl
assist
xray
crystallograph
studi
also
thank
dr
alejandro
ramirez
mass
spectrometri
core
facil
baylor
univers
mass
spectroscop
analysi
dr
craig
moehnk
assist
nmr
studi
dr
jame
